下一步，山东健康将充分利用"鲁链优品"品牌资源优势，持续深化技术创新与工艺优化，进一步巩固和 扩大产业优势，积极拓展国内外高端市场，将优质品牌推向更大更广阔的舞台。 记者了解到，近年来，新华医疗持续加大研发投入，快速提升创新能级，推动创新成果落地转化，其中 脉动真空灭菌器获得第八批国家级制造业单项冠军称号，为医疗机构感控工作提供了高效、安全的解决 方案；基于多模式引导的高能医用电子直线加速器打破了国外品牌的长期垄断，在安全性、有效性和质 量管理体系上达到了国际先进标准。康源堂公司经过多年自主研发，掌握了成熟的蟾酥提取工艺及制备 方法，蟾酥产品获评山东省制造业单项冠军产品。 据山东省国资委1月28日消息，近日，2025年第一批"山东制造.鲁链优品"名单公布，山东健康集团所属 新华医疗（600587）的脉动真空灭菌器、基于多模式引导的高能医用电子直线加速器和康源堂公司的蟾 酥入选。 "山东制造.鲁链优品"品牌建设工程是山东省为深化制造业品牌培育、推动重点产业链优化升级而实施 的重要举措。山东健康集团坚定践行"主业引领、双轮驱动、两端发力、轻重结合、创新发展"的发展方 略，聚焦高端医疗设备、生命科技、生物医药等领域 ...

Core Viewpoint - Sunshine Nuohong's acquisition of Jiangsu Langyan Life Science Technology Co., Ltd. has been terminated due to changes in the market environment, marking the second failed attempt since 2022 [1][3][5] Group 1: Acquisition Details - On January 28, Sunshine Nuohong announced the termination of the major asset restructuring, which involved acquiring 100% of Langyan Life's shares through the issuance of shares and convertible bonds [2][4] - The restructuring process began in April 2025 and was accepted by the Shanghai Stock Exchange in November 2025 [2][5] - Langyan Life specializes in the R&D, production, and sales of high-end chemical drug formulations and raw materials, aiming to become a professional manufacturer and service provider in the pharmaceutical sector [2][5] Group 2: Financial Performance of Langyan Life - Langyan Life's revenue showed fluctuations, with reported revenues of approximately 510 million yuan and 617 million yuan for 2021 and 2022, respectively, and a decline to about 463 million yuan, 415 million yuan, and 231 million yuan for 2023, 2024, and the first half of 2025 [5] - Corresponding net profits were approximately 37.54 million yuan and 85.13 million yuan for 2021 and 2022, with a decrease to around 32.15 million yuan, 55.21 million yuan, and 48.75 million yuan for the subsequent years [5] Group 3: Reasons for Termination - The termination was attributed to changes in the market environment and the need to protect the interests of the company and its shareholders, as stated by the board of directors [3][6] - The company did not respond to the Shanghai Stock Exchange's inquiry letter within the required timeframe, leading to the decision to terminate the transaction [7][8] - The challenges faced during the acquisition process reflect the complexities of executing asset restructurings in the biopharmaceutical industry, including valuation uncertainties and strict regulatory scrutiny [6][8]

Group 1 - The core trend in the Hong Kong IPO market is the surge in companies applying for listings, with nearly 100 companies submitting applications to the Hong Kong Stock Exchange (HKEX) in January alone, indicating a strong momentum for the "A+H" listing strategy [1][4] - The majority of companies applying for IPOs are from sectors such as software services, hardware, semiconductors, biomedicine, medical devices, and consumer goods, reflecting a diverse interest across industries [2][3] - Notably, over ten biopharmaceutical companies are pursuing IPOs under Chapter 18A of the HKEX listing rules, focusing on unmet medical needs in oncology and immunology, showcasing the growing importance of the biotech sector in Hong Kong [2] Group 2 - Consumer brands are also actively seeking listings, with over ten well-known companies in the food and beverage, restaurant chain, and retail sectors submitting applications, indicating a robust interest in the consumer market [3] - The trend of A-share companies applying for Hong Kong listings is driven by the need to enhance global strategies, broaden financing channels, and accelerate overseas business development, positioning Hong Kong as a key platform for international market access [4] - The CEO of Goldman Sachs anticipates a strong recovery in the Hong Kong IPO market in 2026, with expectations for significant increases in both the number of IPOs and the scale of financing, provided that macroeconomic conditions remain stable [4] Group 3 - Despite the IPO boom, there are concerns regarding the quality of applications, with some companies submitting incomplete or poorly prepared documents, leading to scrutiny from the market [5] - The CEO of HKEX emphasized the importance of maintaining high-quality standards for IPO applications, stating that the recent influx of applications has put pressure on resources and collaboration, which could compromise quality [5]

Group 1: Development and Investment - The Xiong'an New Area has maintained an annual investment scale of 200 billion yuan since the 14th Five-Year Plan, with cumulative investments exceeding 1 trillion yuan and an average annual GDP growth of 17.1% [5] - The area is focused on balancing rapid development with sustainable urban planning, emphasizing the importance of both speed and quality in modern city construction [1][5] Group 2: Innovation and Technology - Blue Arrow Hongqing, a company specializing in low-orbit broadband satellite internet, has made significant progress, with the "Xiong'an No. 1" satellite expected to launch in the first half of 2026 [2] - The establishment of Xiong'an Miaoxin Biotechnology Co., which aims to build clinics and has attracted top scientists, highlights the rapid growth of innovative enterprises in the region [3] Group 3: Infrastructure and Community - The China Sinochem Tower, the tallest building in Xiong'an, is set to house nearly a thousand employees by October 2025, contributing to the area's industrial cluster and talent aggregation [4] - The Xiong'an New Area has developed over 740,000 acres of green space, integrating ecological corridors with community and industrial zones to enhance the quality of life [8]

Core Insights - The government work report emphasizes practical measures and innovative concepts to drive economic development in Fujian, showcasing a commitment to integrating new ideas with local realities [1][2]. Group 1: Industry Development Strategies - The report outlines the "Four Chains" integration strategy, focusing on the synergy between innovation, industry, finance, and talent to enhance the entire industrial process [3]. - The "555X" industrial development framework aims to establish a robust industrial pyramid with five trillion-level clusters, five five-hundred billion-level clusters, five hundred billion-level clusters, and X future industries, promoting a strong manufacturing province [4]. - The report highlights the importance of digital transformation and the integration of digital and real economies, positioning Fujian as a leader in digital economic development [6]. Group 2: Business Environment and Support - The "Four Connections and Four Arrivals" mechanism is introduced to optimize services for enterprises, ensuring efficient communication and support while maintaining a clean and cooperative government-business relationship [5]. - The report emphasizes the development of the "Ticket Root Economy" and "Night Economy," leveraging consumer experiences to stimulate economic activity through interconnected consumption scenarios [7]. Group 3: Cultural and Social Initiatives - The report discusses the "Four No Separation" mutual assistance elderly care model, which focuses on providing care in familiar environments, addressing emotional needs while ensuring quality care [11]. - It also emphasizes the continuation and innovative development of Fujian's diverse cultural heritage, aiming to integrate cultural assets into contemporary life and industry, enhancing the region's soft power [12]. Group 4: Infrastructure and Connectivity - The report mentions the initiation of 33 "Two Connections" projects, enhancing transportation links and benefiting nearly 300 million people, thereby facilitating rural revitalization and regional economic growth [10]. - The establishment of cross-strait standardization aims to reduce barriers for Taiwanese businesses, promoting closer economic cooperation and integration between the two regions [9].

Group 1 - The company forecasts a total profit loss of between -167 million to -143 million yuan for the year 2025, with a net profit attributable to the parent company also expected to be in the same range [3][4] - The expected net profit attributable to the parent company, after deducting non-recurring gains and losses, is projected to be between -191 million to -162 million yuan [4] - The anticipated operating revenue for 2025 is estimated to be between 45 million to 50 million yuan, representing a year-on-year increase of 78.46% to 98.29% [4] Group 2 - In the same period last year, the company reported a total profit loss of -151.37 million yuan and a net profit attributable to the parent company of -151.37 million yuan [6] - The net profit attributable to the parent company, after deducting non-recurring gains and losses, was -166.75 million yuan [6] - The operating revenue for the previous year was 25.22 million yuan [8] Group 3 - The increase in sales revenue is attributed to the market introduction of the product "Aofumin" (recombinant human albumin injection) [9] - The production line for the related product is currently in a ramp-up phase, with capacity expected to gradually increase [9] - The company continues to maintain high levels of investment in research and development [10]

本次洽谈会由天津市贸促会主办，吸引了我市50余家科技型企业参会，来自俄罗斯、乌兹别克斯坦、哈 萨克斯坦等上合组织国家的约100名采购商和工商机构代表出席活动。洽谈会采用了"行业分区+精准匹 配"的模式，通过精准筛选、定向匹配实现高效对接。活动中，我市20余家企业与外方达成了初步合作 意向，部分外商有计划赴天津实地考察。 天津市贸促会相关负责人表示，结合我市重点行业的特点和实际需求，市贸促会将继续举办系列专场活 动，为企业"走出去"提供全链条支持，让更多天津品牌、中国产品通过多元渠道走向全球。 （来源：天津日报） 转自：天津日报 本报讯（记者 马晓冬）日前，"津帆出海·贸促护航"——天津科技企业"走出去"贸易投资洽谈会在北京 国家会议中心举办，150余名中外嘉宾会聚一堂。参会企业涉及新能源、智能制造、生物医药、农业、 食品、物流等多个行业。 ...

Core Viewpoint - Jiangsu Province's GDP for 2025 is projected to reach 14.2 trillion yuan, reflecting a year-on-year growth of 5.3%, showcasing its resilience and commitment to high-quality development amidst complex domestic and international economic environments [1] Economic Growth and Structure - Jiangsu's GDP accounts for approximately 10% of the national total, contributing significantly to the overall economic landscape of China [1] - The growth is driven by structural optimization, technological advancement, and efficiency improvements rather than mere scale expansion [1] Industrial Development - The province's industrial added value is expected to grow by 6.5% year-on-year, with 30 out of 40 major industrial sectors experiencing growth, indicating a 75% growth coverage across industries [2] - Jiangsu ranks first nationally in manufacturing quality development index for five consecutive years, with 54 companies listed among China's top 500 manufacturing enterprises [2] Innovation and Technology - High-tech industries accounted for 52.1% of the province's industrial output, marking a 1.4 percentage point increase from the previous year, with high-tech manufacturing value added growing by 11.9% [2] - Strategic emerging industries in Jiangsu have seen an average annual growth of 8% over the past five years, with leading positions in biomedicine, photovoltaics, and integrated circuits [2] Domestic Demand and Consumption - The total retail sales of consumer goods in Jiangsu are projected to reach 46,394.2 billion yuan, with a year-on-year growth of 3.3% [3] - Significant growth in sectors such as sports events and travel services indicates a robust domestic consumption environment [3] Foreign Trade and Investment - Jiangsu's total foreign trade import and export value is expected to reach 5.95 trillion yuan, with a year-on-year growth of 6%, outpacing the national average by 2.2 percentage points [4] - The province has maintained its position as the top destination for foreign investment in China for eight consecutive years, with a focus on high-tech industries and modern services [4] Income and Balanced Development - The per capita disposable income in Jiangsu is projected to be 57,971 yuan, reflecting a year-on-year increase of 4.6%, with a narrowing income gap between urban and rural residents [4] - All 13 prefecture-level cities in Jiangsu are ranked among the top 100 nationwide, highlighting the province's balanced economic development [4] Future Outlook - Jiangsu's economic achievements are seen as a new starting point for high-quality development, with a commitment to expanding domestic demand and optimizing supply [5][6]

Core Viewpoint - Yuekai Securities, a state-owned comprehensive securities company, emphasizes a culture of compliance, integrity, professionalism, and stability, aiming to become a boutique broker in the Guangdong-Hong Kong-Macao Greater Bay Area, focusing on long-term investments in sectors like new energy, biomedicine, commercial aerospace, and low-altitude economy [1][2] Strategic Advantages - The company leverages its "professional judgment" and "state-owned attributes" to support patient capital, focusing on long-term value rather than short-term returns [2][3] - By enhancing its research capabilities, Yuekai Securities aligns its investment decisions with industry trends and project potential, identifying quality targets for long-term partnerships [2][3] Industry Focus - The company is strategically investing in new energy, biomedicine, commercial aerospace, and low-altitude economy, avoiding short-term speculation and focusing on technology-driven enterprises with core technologies and long-term growth potential [5][6] - The global market for AI data center energy storage batteries is projected to grow nearly 20 times from approximately 15 GWh in 2025 to over 300 GWh by 2030, indicating significant opportunities in the new energy sector [4] Investment Practices - Yuekai Securities adopts a "slow investment" approach, which involves patient capital and deep empowerment, allowing companies to navigate challenges and focus on core technology development [5][6] - The company has established a comprehensive empowerment system that integrates investment, investment banking, and wealth management, supporting companies throughout their growth cycles [6][7] Case Studies - In the low-altitude economy, Yuekai Capital led a strategic investment in XPeng Huitian, facilitating the construction of the world's first mass production flying car factory, with over 5,000 orders expected for delivery by 2026 [6][7] - In the biomedicine sector, Yuekai Capital has supported innovative companies like Anjisheng Biotech, accelerating the global clinical development of breakthrough treatments for severe diseases [7] Economic Impact - The company's investments are driving the formation of industrial clusters in commercial aerospace and low-altitude economy, contributing to regional industrial structure optimization and high-quality economic development [7]

● 本报记者 熊彦莎 连润 1月28日，云南、重庆进入两会时间。近日，多地陆续召开地方两会，纷纷定下各自的2026年经济发 展"路线图"。 中国证券报记者梳理发现，多地将2026年GDP增长预期目标定在5%左右。从重点目标任务看，扩大内 需，强化科技创新支撑引领、构建现代化产业体系等居于重要位置。各地对人工智能的部署更加注重数 据集建立、场景应用。 扩大内需潜力 2026年经济增长预期目标是各地两会颇受关注的内容。海南、新疆2026年地区生产总值增长预期目标分 别为6%左右、5.5%至6%；广东、山东、浙江、河南提出2026年地区生产总值增长预期目标分别为4.5% 至5%、5%以上、5%至5.5%、5%左右。此外，北京、天津、重庆提出2026年地区生产总值增长分别为 5%左右、4.5%和5%以上。 扩大内需成为各地2026年重点部署的任务之一。推动消费转型升级、拓展新型消费、释放服务消费潜力 成为地方两会出现的高频词。北京提出，加大对教育、健康、养老、托育等服务消费政策支持，鼓励平 台创新发展家政等服务业务。浙江提出，拓展消费新业态新模式新场景；加快发展数智消费、悦己消 费、银发经济等新型消费，扩大文旅、餐饮 ...